Table 5 Treatment-related adverse events.

From: Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy

Event

All grades No.(%)

Grade 1

Grade 2

Grade 3

Grade 4

Stomatitis

27 (90.00)

26

1

0

0

Headache

11 (36.67)

11

0

0

0

Upper respiratory tract infection

5 (16.67)

4

1

0

0

Urinary tract infection

0

0

0

0

0

Nausea

4 (13.33)

4

0

0

0

Vomit

5 (16.67)

5

0

0

0

Acne-like skin lesions

8 (26.67)

8

0

0

0

Fatigue

4 (13.33)

4

0

0

0

Cough

8 (26.67)

8

0

0

0

Hypercholesterolemia

4 (13.33)

4

0

0

0

Bleeding

0

0

0

0

0

Cytopenia

4 (13.33)

3

1

0

0

*Menstrual disorders

4 (23.53)

0

4

0

0

  1. *Percentage statistics only record the total number of non-menopausal female patients (n = 17).